Pharma and Twitter: a happy marriage or time for a divorce?
September 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Facebook, PMCPA, Twitter, digital, pharma, social media
There has been a phenomenal rise in the use and scale of social media over the past decade, from the …
GSK fined, executives face jail sentence in Chinese bribery case
September 19, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery, sex tape
China has fined Britain’s largest pharma firm GlaxoSmithKline $490 million (£297m) for corruption after a year-long investigation into claims it …
Boehringer pays $600m for cancer vaccine deal
September 19, 2014Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1
Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …
‘Angelina effect’ sees BRCA tests soar in UK
September 19, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, angelina jolie, brac1, brad, breast, mastectomy
Referrals for testing for breast cancer risk more than doubled across the UK, after Oscar-winning American actress Angelina Jolie announced …
Changes at the top for Merck KGaA
September 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Belén Garijo, Merck KGaA, Stefan Oschmann
German chemical and pharma giant Merck KGaA has promoted Stefan Oschmann to the position of deputy chief executive and vice …
Scotland votes no for independence
September 19, 2014Medical Communications, Research and Development, Sales and Marketing NHS, Scotland
The United Kingdom remains united today as Scotland narrowly voted against breaking up the 307-year-old union. The ‘No, Better Together’ …
Astellas appoints comms head from Baxter
September 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris
Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …
Apple’s HealthKit plagued by bugs and delay
September 18, 2014Medical Communications, Sales and Marketing Apple, Samsung, digital, google, health kit, ios8, wearables
Apple’s new mobile software iOS8 was launched around the world yesterday but the eagerly anticipated centrepiece HealthKit app was conspicuous …
GSK melanoma drug sees quick NICE nod
September 18, 2014Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer
NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …
NICE reform put on hold – for now
September 17, 2014Sales and Marketing Dillon, NHS, NHS England, NICE, market access, vba
The reforming of NICE has been put on hold as the watchdog believes more changes must be wrought to deal …
New managing director for PAN
September 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Jon Linscott, Pan, eric hansen
Creative comms agency PAN has appointed a new managing director in Eric Hansen who replaces the recently-departed Jon Linscott.Reporting in …
Cancer drug gains first early UK access grant
September 17, 2014Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising
A new type of cell therapy for cancer has become the first to be deemed by the UK government as …
Epic Sciences hires regulatory affairs VP
September 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing epic sciences, paul frieberg
San Diego-based cancer diagnostics firm Epic Sciences has appointed Glen Paul Freiberg as its vice president of regulatory affairs and …
Pfizer partners with MedGenesis on Parkinson’s
September 16, 2014Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience
Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …
Pharma exports in UK help drive the economy
September 16, 2014Manufacturing and Production, Sales and Marketing UK, emerging markets, exports, hsbc, imports, pharma
The UK’s pharmaceutical sector is ‘an export success story’, enjoying a competitive advantage and generating a sizeable trade surplus. This …
Roche should be ‘shamed’ into lowering cancer drug price
September 16, 2014Medical Communications, Sales and Marketing Kadcyla, Margaret Connolly, Roche, Swiss, breast cancer, trastuzumab emtansine
A public petition to force Roche to lower the cost of its costly new breast cancer drug Kadcyla has been …
AstraZeneca teams up with rival Lilly for Alzheimer’s
September 16, 2014Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly
AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …
Gilead allows generic prices for Sovaldi
September 16, 2014Manufacturing and Production, Sales and Marketing Gilead, hep C, hepatitis C, sofosbuvir, sovaldi
Gilead will allow Indian generic drug firms to make cheap copies of its new hepatitis C pill Sovaldi in an …
No silver bullet, but a growing arsenal for pharma comms
September 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck, comms, eyeforpharma, mcm, selincro, tim white
Digital strategies in the pharma industry have predominately been a red herring, focussing too much on the novelty of digital …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
